A1 Refereed original research article in a scientific journal

Trends and results of oesophageal cancer surgery in Finland between 2004 and 2014




AuthorsOlli Helminen, Eero Sihvo, Jarmo Gunn, Jussi O T Sipilä, Päivi Rautava, Ville Kytö

Publication year2020

JournalEuropean Journal of Cardio-Thoracic Surgery

Journal name in sourceEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Journal acronymEur J Cardiothorac Surg

Volume57

Issue1

First page 107

Last page113

ISSN1010-7940

eISSN1873-734X

DOIhttps://doi.org/10.1093/ejcts/ezz189


Abstract
OBJECTIVES

Few population-based studies reporting trends in oesophageal cancer surgery exist. The aim of this study was to assess the incidence of oesophageal cancer, changes in resection rates, patient demographics and short- and long-term outcomes of oesophagectomy at the population level in Finland.

METHODS

All Finnish patients diagnosed with cancer of the oesophagus or gastrooesophageal junction between 1 January 2004 and 31 December 2014 identified from the nationwide registries were included. The follow-up ended on 31 December 2016. For evaluation of changes in demographics and treatment, data were divided into 2 periods: 2004–2009 and 2010–2014. For comparison of short-and long-term outcomes, adjustments for age, sex, comorbidity, tumour stage and histology were used.

RESULTS

The number of diagnosed oesophageal cancers was 4266. Of these, 740 underwent oesophagectomy. Resection rate increased from 15.2% in 2004–2009 to 19.6% in 2010–2014. The median number of oesophagectomies in Finnish hospitals increased from 1.9 to 3.7 per hospital per year. At the same time, minimally invasive surgery became more common (6.3% vs 35.1%, P < 0.0001) and a trend for increase in neoadjuvant treatment was observed (46.8% vs 53.8%, P = 0.0582). The rate of type III anastomosis leaks and conduit necroses was 5.1% without differences in time periods. Three-year [52.4% vs 61.6%, adjusted hazard ratio (HR) 0.75, 95% confidence interval (CI) 0.59–0.95] and 5-year survival (42.1% vs 56.5%, adjusted HR 0.70, 95% CI 0.57–0.87) improved.

CONCLUSIONS

This nationwide population-based study demonstrates an increase in resection rate, use of neoadjuvant treatment and minimally invasive surgery together with an improvement in long-term outcome after oesophageal cancer surgery.



Last updated on 2024-26-11 at 18:32